Verve Therapeutics, Inc. - Common Stock (NQ:VERV)

11.13 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 24, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Verve Therapeutics, Inc. - Common Stock

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Why Beam Therapeutics Stock Is Getting Bought Today ↗

October 31, 2023

Beam Therapeutics Inc (NASDAQ: BEAM) shares are trading higher Tuesday after Eli Lilly And Co (NYSE: LLY) agreed to acquire certain rights under Beam's

Via Benzinga

Verve and Lilly Relationship Expands to Include Verve’s In Vivo Gene Editing Programs Targeting PCSK9 and ANGPTL3

October 31, 2023

Lilly Purchases Product Rights to Verve’s Lead Cardiovascular Programs from Beam Therapeutics

From Verve Therapeutics

Via GlobeNewswire

With 1 Roadblock Down, Is Verve Therapeutics a Buy Now? ↗

October 30, 2023

It takes more than starting a clinical trial to make for a good investment.

Via The Motley Fool

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 27, 2023

Via Benzinga

1 Cathie Wood Stock That Could Go Parabolic Soon ↗

August 31, 2023

This next-gen biotech stock is barreling toward a major catalyst.

Via The Motley Fool

Expert Ratings for Verve Therapeutics ↗

August 29, 2023

Via Benzinga

Verve Therapeutics Announces Clearance of Investigational New Drug Application by the U.S. FDA for VERVE-101 in Patients with Heterozygous Familial Hypercholesterolemia

October 23, 2023

From Verve Therapeutics

Via GlobeNewswire

2 Incredible Growth Stocks Near 52-Week Lows to Buy Now ↗

October 10, 2023

These two high-tech bio companies may be too cheap to ignore right now.

Via The Motley Fool

Why TD SYNNEX Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

September 26, 2023

Gainers Soleno Therapeutics, Inc. (NASDAQ: SLNO) shares jumped 318.5% to $18.54 after the company released top-line results from randomized withdrawal period of study C602 of DCCR for Prader-Willi...

Via Benzinga

Fisker, Intercept Pharmaceuticals, Immunovant And Other Big Stocks Moving Higher On Tuesday ↗

September 26, 2023

U.S. stocks traded lower, with the Dow Jones falling around 200 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Verve to Present Interim Data from the heart-1 Phase 1b Clinical Trial of VERVE-101 in HeFH Patients at the American Heart Association’s Scientific Sessions 2023

September 26, 2023

Company to hold investor event in conjunction with data presentation on November 12, 2023

From Verve Therapeutics

Via GlobeNewswire

Verve Therapeutics to Participate in the 2023 Cantor Global Healthcare Conference

September 21, 2023

From Verve Therapeutics

Via GlobeNewswire

Verve Expands Leadership Team with Appointment of Frederick T. Fiedorek, M.D., as Chief Medical Officer

September 18, 2023

From Verve Therapeutics

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Tuesday ↗

August 29, 2023

On Tuesday, 99 stocks hit new 52-week lows.

Via Benzinga

Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss ↗

August 10, 2023

The disinflationary trend continued in July, even though the annual CPI inflation rate saw a slight increase from 3% to 3.2% last month, breaking a streak of 12 consecutive months of decline.

Via Benzinga

Topics ETFs Economy

Verve Therapeutics Highlights Recent Company Progress and Reports Second Quarter 2023 Financial Results

August 10, 2023

From Verve Therapeutics

Via GlobeNewswire

Verve Therapeutics to Present at the Canaccord 43rd Annual Growth Conference

August 03, 2023

From Verve Therapeutics

Via GlobeNewswire

Jim Cramer Says It's Time To Buy This Financial Services Stock Down 32% YTD ↗

July 21, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Illumina, Inc. (NASDAQ: ILMN) is not even as good as Danaher Corporation (NYSE: DHR).

Via Benzinga

Cathie Wood Is Buying This Biotech, but Here's Why I'm Not ↗

July 13, 2023

The risks are too high, and it'll take a while for them to be addressed.

Via The Motley Fool

Cathie Wood Buys More Meta Shares As Mark Zuckerberg Goes All-In On Twitter Rivalry ↗

July 07, 2023

Via Benzinga

Cathie Wood Continues To Sell Tesla Shares Amid Q2 Deliveries-Induced Strength: Here's How Much Shares Ark Offloaded Monday ↗

July 03, 2023

Via Benzinga

Verve Therapeutics Gains 20.74% In June as Ark Funds Invest

June 30, 2023

Verve Therapeutics' efforts to eliminate cardiovascular disease through gene-editing treatments have momentum, as the stock gets a 20.74% boost in June.

Via MarketBeat

5 Short Squeeze Stocks In Play Thursday: Nikola, Verve, Carvana, More ↗

June 15, 2023

Via Benzinga

Crude Oil Rises Sharply; Jabil Posts Upbeat Q3 Results ↗

June 15, 2023

U.S. stocks traded higher toward the end of trading, with Dow Jones gaining around 450 points on Thursday. The Dow traded up 1.32% to 34,429.39 while the NASDAQ rose 1.27% to 13,799.28. The S&P 500,...

Via Benzinga

Eli Lilly Just Lent Its Big Pharma Cachet To Verve's Nascent Gene-Editing Program For $60 Million ↗

June 15, 2023

Eli Lilly inked a deal worth $60 million to get in on a gene-editing drug for elevated lipoprotein A.

Via Investor's Business Daily

Domino's Pizza, Patterson-UTI Energy, JinkoSolar And Other Big Stocks Moving Higher On Thursday ↗

June 15, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 180 points on Thursday. Here are some big stocks recording gains in today’s session. Nikola Corporation (NASDAQ: NKLA) jumped 19.9% to...

Via Benzinga

Verve Therapeutics to Participate in the 2023 Jefferies Healthcare Conference

June 01, 2023

From Verve Therapeutics

Via GlobeNewswire

Verve Therapeutics to Participate in the Stifel 2023 Tailoring Genes: Virtual Genetic Medicines Day

May 23, 2023

From Verve Therapeutics

Via GlobeNewswire

Verve Therapeutics Announces Pipeline Progress and Expansion and Reports First Quarter 2023 Financial Results

May 15, 2023

From Verve Therapeutics

Via GlobeNewswire

Why These 3 Nasdaq Stocks Were Glowing Green This Week ↗

May 11, 2023

These three biopharmaceutical stocks rocketed higher this week.

Via The Motley Fool

< Previous 1 2

...

6 7 8 9 10 11 12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.